IBUSTRIN, A TROMBOXANE SYNTHESIS INHIBITO R, IN THE TREATMENT OF DIABETIC ANGIOPATHY

16 patients with insulin-dependent diabetes mellitus (IDDM) lasting 8- 19 years had pronounced diabetic nephropathy (proteinuria stage), reti nopathy (stage I, II or III), disturbed circulation in the lower limbs detected at foot dopplerography. For 3 months these patients received ibustrin (inhibitor of cyclooxigenase, blocker of tromboxane A2 synth esis and platelet aggregation) before renal function underwent positiv e changes: glomerular filtration rate increased in 13 patients (81%), 24-h proteinuria decreased in 12 patients (75%). Retinal vascular cond ition improved in 5 of 6 patients with nonproliferative retinopathy an d in 2 of 5 patients with preproliferative retinopathy, in 1 and 3 pat ients stabilization occurred, respectively. In proliferative retinopat hy improvement and stabilization were registered in 1 and 3 of 5 patie nts, respectively. According to feet artery dopplerography the improve ment, no changes and moderate aggravation occurred in 10(62%), 3(19%) and 3(19%) of patients, respectively. The conclusion is made that ibus trin effectively inhibits progression of IDDM vascular complications, especially at early angiopathy stages.